CN118546165A - 青蒿素衍生的三聚体和四聚体及其用途 - Google Patents

青蒿素衍生的三聚体和四聚体及其用途 Download PDF

Info

Publication number
CN118546165A
CN118546165A CN202410656901.XA CN202410656901A CN118546165A CN 118546165 A CN118546165 A CN 118546165A CN 202410656901 A CN202410656901 A CN 202410656901A CN 118546165 A CN118546165 A CN 118546165A
Authority
CN
China
Prior art keywords
compound
cancer
chr
art
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202410656901.XA
Other languages
English (en)
Chinese (zh)
Inventor
赵鸣
周丽明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CN118546165A publication Critical patent/CN118546165A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
CN202410656901.XA 2017-11-21 2018-11-21 青蒿素衍生的三聚体和四聚体及其用途 Pending CN118546165A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201762588921P 2017-11-21 2017-11-21
US62/588,921 2017-11-21
CN201880075374.6A CN111372583B (zh) 2017-11-21 2018-11-21 青蒿素衍生的三聚体和四聚体及其用途
PCT/US2018/062356 WO2019104247A1 (en) 2017-11-21 2018-11-21 Artemisinin-derived trimers and tetramers and their use thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201880075374.6A Division CN111372583B (zh) 2017-11-21 2018-11-21 青蒿素衍生的三聚体和四聚体及其用途

Publications (1)

Publication Number Publication Date
CN118546165A true CN118546165A (zh) 2024-08-27

Family

ID=66632152

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202410656901.XA Pending CN118546165A (zh) 2017-11-21 2018-11-21 青蒿素衍生的三聚体和四聚体及其用途
CN201880075374.6A Active CN111372583B (zh) 2017-11-21 2018-11-21 青蒿素衍生的三聚体和四聚体及其用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201880075374.6A Active CN111372583B (zh) 2017-11-21 2018-11-21 青蒿素衍生的三聚体和四聚体及其用途

Country Status (5)

Country Link
US (2) US11358970B2 (https=)
EP (1) EP3713566A4 (https=)
JP (1) JP7282294B2 (https=)
CN (2) CN118546165A (https=)
WO (1) WO2019104247A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11358970B2 (en) * 2017-11-21 2022-06-14 Ming Zhao Artemisinin-derived trimers and tetramers and their use thereof
JP7534726B2 (ja) * 2019-02-26 2024-08-15 マフムード エイ エルソーリー リーシュマニア症の処置用に選択されたアーテミシニンダイマー
CN113264946A (zh) * 2021-05-11 2021-08-17 中国人民解放军陆军军医大学第一附属医院 一种双氢青蒿素衍生物及其在制备治疗、预防脑血管病药物中的应用
CN115282145A (zh) * 2022-09-05 2022-11-04 中南大学湘雅二医院 青蒿琥酯在制备治疗青光眼的药物或制剂中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100529600B1 (ko) 2003-01-23 2005-11-22 정만길 디옥소아테미시닌 유사체, 그의 제조방법 및 그를포함하는 항암제
SG174483A1 (en) 2009-03-24 2011-10-28 Univ Singapore Use of artemisinin derivatives for the treatment of asthma and chronic obstructive pulmonary disease (copd)
DK2424880T3 (en) * 2009-04-28 2016-10-24 Res Dev Foundation Immunoreactive Ehrlichia p120 / p140 epitopes, and uses thereof
US8884032B2 (en) * 2009-05-19 2014-11-11 The Johns Hopkins University Trioxane monomers and dimers
WO2011071981A2 (en) 2009-12-08 2011-06-16 The Johns Hopkins University Anti-cytomegalovirus activity of artemisinin-derived dimers
CN102153564B (zh) 2011-01-31 2013-07-24 中国科学院上海药物研究所 含氮原子的青蒿素二聚体、其制备方法及用途
ES2643182T3 (es) 2011-06-10 2017-11-21 Queen Mary University Of London Artemisinina y derivados para uso en el tratamiento de hemorragia por trauma
CN103450468B (zh) * 2012-05-30 2016-06-15 北京凯正生物工程发展有限责任公司 青蒿琥酯聚乙二醇化衍生物、其药物组合物及其用途
EP2931283B1 (en) 2012-12-12 2020-04-08 Queen Mary and Westfield College University of London Artemisinin and its derivatives for use in the treatment of kidney disease
US9314460B1 (en) * 2013-04-09 2016-04-19 Stc.Unm Method for cancer cell reprogramming
CN105078964A (zh) 2015-08-20 2015-11-25 桂林医学院附属医院 青蒿琥酯在制备治疗特发性肺纤维化药物中的应用
US11358970B2 (en) * 2017-11-21 2022-06-14 Ming Zhao Artemisinin-derived trimers and tetramers and their use thereof
CN109467565B (zh) 2018-08-16 2020-07-10 云白药征武科技(上海)有限公司 双氢青蒿素三聚体及其制备方法和应用

Also Published As

Publication number Publication date
WO2019104247A1 (en) 2019-05-31
US20210079011A1 (en) 2021-03-18
US11358970B2 (en) 2022-06-14
EP3713566A4 (en) 2021-07-14
CN111372583A (zh) 2020-07-03
CN111372583B (zh) 2024-06-14
US12134624B2 (en) 2024-11-05
JP2021504302A (ja) 2021-02-15
EP3713566A1 (en) 2020-09-30
US20220275003A1 (en) 2022-09-01
JP7282294B2 (ja) 2023-05-29

Similar Documents

Publication Publication Date Title
US12134624B2 (en) Artemisinin-derived trimers and tetramers and their use thereof
US20110076293A1 (en) Triptolide derivatives for modulation of apoptosis and immunosuppression
EP2615092B1 (en) Heterocyclic amino berbamine derivatives, preparation method and use thereof
JP5057966B2 (ja) 免疫調節剤および抗癌剤としてのトリプトライドラクトン環誘導体
CA3217111A1 (en) Use of medicament in treatment of tumor disease
CN111662294A (zh) 一类具有降解Btk活性的化合物
KR20250110848A (ko) Sting 작용제로서 헤테로사이클릭 화합물
JP2019521950A (ja) アルテスナート含有組成物
CN109879933A (zh) 一类含磷酰基化合物及其应用
EP2610257B1 (en) Diimidated derivative of berbamine, and preparation method therefor and use thereof
CN113024422A (zh) 丁苯酞开环化合物、药物化合物以及它们的制备方法、组合物和应用
CN113490669A (zh) 一类具有降解Btk活性的化合物
CN116239640B (zh) 吉西他滨前药及其医药用途
AU2015355965B2 (en) Novel PEG derivative
KR20080081310A (ko) 항암 효과가 높고 항말라리아 활성이 오래 지속되는트리옥산 이량체
KR20250003936A (ko) 피리미디논 함유 17-베타-하이드록시스테로이드 탈수소효소 유형 13 억제제
AU2022322810A1 (en) Class of cddo/tetramethylpyrazine alcohol heterocomplexes having combination therapy effect, and preparation method therefor and use thereof
CN100443486C (zh) 7-酯化和7,20-双酯化的喜树碱衍生物及其制法和其药物组合物与用途
CN102838652B (zh) 一种具有抗恶性肿瘤作用的齐墩果酸衍生物及其制备方法和用途
CN116947765B (zh) 一种抗肿瘤药物前药、药物组合物及在肿瘤靶向治疗领域的应用
CN101747300B (zh) 基于紫杉醇和氮芥的协同前药及其制备方法
CN117897386A (zh) 苯并吡喃衍生物及其用途
CN113637031A (zh) 一种结构新颖的二价铂类化合物及其用途
US20060160895A1 (en) Anti-cancer agents
JP2003128581A (ja) 副作用予防薬または軽減薬

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination